2014
DOI: 10.1016/j.pupt.2013.05.002
|View full text |Cite
|
Sign up to set email alerts
|

Airway responsiveness to adenosine after a single dose of fluticasone propionate discriminates asthma from COPD

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 37 publications
0
3
0
Order By: Relevance
“…with the bronchodilator response [176]. Like other indirect challenge tests, the adenosine challenge test may be particularly useful to ascertain the effects of anti-inflammatory therapies such as inhaled steroids in asthma [177][178][179][180][181].…”
Section: Adenosine Challenge Testingmentioning
confidence: 99%
“…with the bronchodilator response [176]. Like other indirect challenge tests, the adenosine challenge test may be particularly useful to ascertain the effects of anti-inflammatory therapies such as inhaled steroids in asthma [177][178][179][180][181].…”
Section: Adenosine Challenge Testingmentioning
confidence: 99%
“…On this basis, it has been argued persuasively that adenosine bronchial challenge testing is a better non-invasive tool for monitoring disease activity and an improved method for assessing the response to anti-inflammatory treatments [7]. Moreover, recent findings suggest that bronchial challenging with adenosine may improve diagnostic discrimination between asthma and COPD [8]. …”
Section: Introductionmentioning
confidence: 99%
“…However, nebulisation of AMP has a number of drawbacks. First, the maximum aerosol droplet AMP concentration (300–400 mg/mL; restricted by the nebuliser solution’s viscosity) does not result in AHR in all patients [8, 9]. Furthermore, nebuliser solution AMP concentrations > 20 mg/mL have been shown to greatly affect aerosol formation, which may have implications for the test outcome, such as a shift in deposition site or disproportional dose increase [10].…”
Section: Introductionmentioning
confidence: 99%